论文部分内容阅读
目的评估B超引导下经皮肝穿刺注射无水乙醇结合肝动脉化疗栓塞治疗中晚期原发性肝癌的时机选择与疗效。方法对52例中晚期原发性肝癌采用B超引导下经皮肝穿刺瘤内注射无水乙醇(PEI)+肝动脉插管化疗栓塞术(TACE)治疗并与同期58例单纯肝动脉化疗栓塞术(对照组)比较。结果治疗组的肿瘤缩小率、AFP下降、Karnofsky评分、0.5、1年累计生存率明显优于对照组。结论PEI+TACE为中晚期原发性肝癌较好的一种综合治疗方法。
Objective To evaluate the timing and efficacy of transcatheter hepatic arterial chemoembolization with percutaneous transhepatic liver biopsy in the treatment of advanced primary liver cancer. Methods Fifty-two patients with primary hepatocellular carcinoma of the middle and advanced stages underwent transcatheter percutaneous transhepatic cardiothoracic nephrectomy (PEI) plus hepatic arterial chemoembolization (TACE) under the guidance of ultrasound and 58 patients with simple hepatic arterial chemoembolization Surgery (control group) comparison. Results In the treatment group, the tumor shrinkage rate, AFP decreased, Karnofsky score, 0.5 year cumulative survival rate was significantly better than the control group. Conclusion PEI + TACE is a better treatment of advanced primary liver cancer.